Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.
CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided...
Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.
Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or...
3M to Acquire Wound Care Technology Co., Acelity for $6.7 Billion.
Chronic wounds represent a large and growing threat to public health. In the US alone, they affect over 6.5 million people. As the population...
Lift Off! Mustang Bio (MBIO) $9.31 Jumps 4-Fold.
‘Bubble Boy’ Biotech Soars 250 Percent After Cure Announcement (Bloomberg).
(Bloomberg) -- Shares of the tiny biotechnology company Mustang Bio Inc. more than tripled Thursday,...
Adding Vaccinex (VCNX) $5.50, to Watch List After Investor Presentation.
IPO Tumbles in Aftermarket, from $12 underwritten by Oppenheimer, BTIG and Ladenburg Thalmann, to a low of $3 in six months.
$40 million was...
Dyadic (DYAI) Uplists to NASDAQ!
JUPITER, FL / ACCESSWIRE / April 15, 2019 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying...
Mustang Bio (MBIO)$4.12, Reports 2018 Results.
Mustang Bio Reports Full-Year 2018 Financial Results And Recent Corporate Highlights
GlobeNewswire - Mon Mar 18, 6:29AM CDT
Mustang Bio, Inc. ("Mustang") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused...
Must Watch Video: Dyadic’s (DYAI) Matthew Jones.
Click here to watch the video. It's the proverbial, "everything you wanted to know" about Cho cells.
"We achieved encouraging results, knowledge and experience in...
Two Biotech Stocks on Takeover List?
Why These 2 Biotech Stocks Might Be Next On The Takeover List (IBD).
Acadia Pharmaceuticals (ACAD) and Neurocrine Biosciences (NBIX) stand out as potential takeover candidates among biotech...














